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Reply to the Editor:
We appreciate the questions and
comments by Drs Chang and McA-
nena in regards to our study, which
demonstrated significantly improved
survival after neoadjuvant therapy
with an en bloc esophagectomy com-
pared with a transhiatal resection.1 Re-
garding the nonrandomized study by
Morganet al that failed to showadiffer-
ence between a transthoracic and tran-
shiatal resection after neoadjuvant
therapy, there are several points that
bear mentioning.2 First, in contrast to
our study, their population was mixed
adenocarcinoma and squamous cell
cancer. Furthermore, although we re-
ported a significantly greater number
of nodes resected with the en bloc re-
section (median 29.5 versus 19 in the
transhiatal group), Morgan et al inex-
plicably reported a median of 13 re-
sected nodes with each procedure.
Last, although our results with tran-
shiatal resection mirror reports from
other centers, their results were un-
usual. They reported a local recurrence
rate of 6% and 5-year survival of 53%
after neoadjuvant therapy and transhia-
tal resection compared with 17% and
22% in our study and 19% and 20%,
respectively, in the randomized Uni-
versity ofMichigan trial.3 These differ-
ences are difficult to explain but may
represent significant selection bias in
the study byMorgan et al and also indi-
cate that although the incision may be
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To the Editor:
Dr Rizzetto and colleagues1 con-
cluded from their retrospective review
of 58 patients that en bloc esophagec-
tomy is the surgical treatment of
choice for adenocarcinoma after neo-
adjuvant therapy. We, however, inter-
pret this strong statement with
a degree of reservations. A larger pro-
spective study involving 151 patients
(of which 116 had adenocarcinoma)
has previously demonstrated no signif-
icant difference in recurrence and sur-
vival between en bloc transthoracic
and transhiatal approaches.2 The dis-
crepancy of result could be due to sev-
eral reasons.
The authors emphasized that despite
a higher age and comorbidity profiles
in the transhiatal arm, deaths in this
group of patients were all cancer-re-
lated but one. However, surgical com-
plication, particularly pulmonary
infection, is an independent factor as-
sociated with poor survival.3 Older pa-
tients with more comorbidities are
inevitably more predisposed to pulmo-
nary complications. This factor, to-
gether with other functional and
nutritional variables such as preopera-
tive albumin level, weight loss, pulmo-
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status, could have skewed the survival
analysis. We feel that by including in-
dices of tumor aggressiveness such as
differentiation, lymphovascular and
perineural invasion status, and the
aforementioned functional and nutri-
tional parameters, a multivariate Cox
regression analysis is a more accurate
means of determining the real impact
of each surgical approach.
Lymph node yield from transhiatal
resections is significantly lower than
that from transthoracic en bloc resec-
tions. The relatively higher proportion
of complete pathologic response in the
transhiatal group (39% vs 25%) could
have been incorrectly overestimated
secondary to fewer lymph nodes re-
trieved. This is reflected in the higher
proportion of patients with stage III
disease in the en bloc group (37.5%
vs 27.8%). The underestimation of pa-
tients with residual disease in the tran-
shiatal group could have led to the
marked difference of 5-year survival
observed between the 2 groups.
We feel that more attention must be
paid to interpreting this study and that
younger and more medically fit pa-
tients might benefit from more aggres-
sive en bloc resection; transhiatal
approach does not necessarily account
for worse oncologic outcomes among
older patients with more comorbid-
ities. If en bloc resection is preferred
based on its more extensive oncologic
dissection, we would be interested in
the authors’ views on 3-field lympha-
denectomy, given the prevalence of
positive cervical nodes shown to be
as high as 24%.4
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